AI Earnings: C3.ai Stock Tumbles after Missing Q1 Expectations, Names New CEO

C3.ai (AI) stock declined 14% after reporting significantly weaker-than-expected Q1 FY26 results, with revenue of $70.3 million missing Street consensus by 25% and a net loss of $0.37 per share being substantially wider than anticipated. The enterprise AI software firm withdrew its full-year guidance and projected a soft Q2, attributing the poor performance to a major sales and services team reorganization and leadership changes, including the appointment of Stephen Ehikian as the new CEO. This signals considerable operational challenges and near-term uncertainty for the company.

Analysis

C3.ai's fiscal Q1 2026 results reveal a company facing severe operational and financial headwinds, triggering a 14% stock decline. The firm reported a significant top-line miss, with revenue of $70.3 million declining 19.3% year-over-year and falling well short of the $93.8 million consensus estimate. Profitability deteriorated sharply, as the net loss per share widened to $0.37, substantially worse than the anticipated $0.21 loss and the prior year's $0.05 loss. The decision to withdraw full-year guidance, coupled with a Q2 revenue forecast of $72-$80 million that is starkly below the $99.6 million consensus, indicates a profound lack of visibility and suggests the negative trend will continue into the next quarter. Management attributes the poor performance to a disruptive sales force reorganization and leadership challenges, which are now being addressed through the appointment of a new CEO, Stephen Ehikian. However, this leadership transition introduces further execution risk at a critical juncture, as acknowledged by the founder's characterization of the performance as "completely unacceptable."

Key Decisions for Investors

• Given the severe earnings miss, withdrawn full-year guidance, and ongoing sales reorganization, investors should exercise extreme caution and anticipate further stock price volatility and potential downward estimate revisions.
• The appointment of a new CEO introduces significant execution risk; performance should be closely monitored, with the Q2 earnings release in December serving as the next critical catalyst for assessing the turnaround strategy's viability.
• The pre-earnings average price target of $23.63 is now highly unreliable, and it would be prudent for investors to await revised Wall Street estimates before re-evaluating any investment thesis or considering new positions.